Ratings MedPeer,Inc.

Equities

6095

JP3921240002

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-13 am EDT			5-day change	1st Jan Change
700 ^JPY	+1.45%		+1.01%	-2.23%

2023	Tranche Update on MedPeer,Inc.'s Equity Buyback Plan announced on May 11, 2023.	CI
2023	MedPeer,Inc.'s Equity Buyback announced on May 11, 2023, has closed with 262,900 shares, representing 1.20% for ¥299.98 million.	CI

Strengths

The company is in a robust financial situation considering its net cash and margin position.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

The company benefits from high valuations in earnings multiples.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Over the past four months, analysts' average price target has been revised downwards significantly.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Internet Services

	1st Jan change	Capi.	ESG Refinitiv
MEDPEER,INC.	-2.23%	96.15M	-
TENCENT HOLDINGS LIMITED	+28.41%	441B	B
NETFLIX, INC.	+25.47%	263B	D+
UBER TECHNOLOGIES, INC.	+8.80%	140B	A-
AIRBNB, INC.	+7.48%	92.89B	C-
PROSUS N.V.	+26.48%	90.53B	B+
SPOTIFY TECHNOLOGY S.A.	+56.78%	58.64B	B-
DOORDASH, INC.	+16.13%	46.96B	C+
COSTAR GROUP, INC.	+2.85%	36.7B	B
NASPERS LIMITED	+20.84%	36.11B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes